These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 8436957)
1. Dopamine D1 agonist SKF 38393 increases the state of phosphorylation of ARPP-21 in substantia nigra. Tsou K; Girault JA; Greengard P J Neurochem; 1993 Mar; 60(3):1043-6. PubMed ID: 8436957 [TBL] [Abstract][Full Text] [Related]
2. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism. Abercrombie ED; DeBoer P J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422 [TBL] [Abstract][Full Text] [Related]
3. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra. Huang KX; Bergstrom DA; Ruskin DN; Walters JR Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877 [TBL] [Abstract][Full Text] [Related]
4. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses. Weick BG; Walters JR Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219 [TBL] [Abstract][Full Text] [Related]
5. Dopamine-regulated phosphorylation of synaptic vesicle-associated proteins in rat neostriatum and substantia nigra. Walaas SI; Sedvall G; Greengard P Neuroscience; 1989; 29(1):9-19. PubMed ID: 2496331 [TBL] [Abstract][Full Text] [Related]
6. ARPP-21, a cAMP-regulated phosphoprotein enriched in dopamine-innervated brain regions: tissue distribution and regulation of phosphorylation in rat brain. Girault JA; Walaas SI; Hemmings HC; Greengard P Neuroscience; 1990; 37(2):317-25. PubMed ID: 1966823 [TBL] [Abstract][Full Text] [Related]
7. Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons. Svenningsson P; Lindskog M; Rognoni F; Fredholm BB; Greengard P; Fisone G Neuroscience; 1998 May; 84(1):223-8. PubMed ID: 9522376 [TBL] [Abstract][Full Text] [Related]
8. D1 agonist-induced excitation of substantia nigra pars reticulata neurons: mediation by D1 receptors on striatonigral terminals via a pertussis toxin-sensitive coupling pathway. Martin LP; Waszczak BL J Neurosci; 1994 Jul; 14(7):4494-506. PubMed ID: 7913124 [TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions. Mango D; Bonito-Oliva A; Ledonne A; Nisticò R; Castelli V; Giorgi M; Sancesario G; Fisone G; Berretta N; Mercuri NB Neuropharmacology; 2014 Jan; 76 Pt A():127-36. PubMed ID: 23973317 [TBL] [Abstract][Full Text] [Related]
10. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output. Huang KX; Walters JR J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding. Engber TM; Marin C; Susel Z; Chase TN Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970 [TBL] [Abstract][Full Text] [Related]
12. Nitric oxide/cGMP pathway stimulates phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, in the substantia nigra. Tsou K; Snyder GL; Greengard P Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3462-5. PubMed ID: 8386374 [TBL] [Abstract][Full Text] [Related]
13. Activation of D1 receptors stimulates accumulation of gamma-aminobutyric acid in slices of the pars reticulata of 6-hydroxydopamine-lesioned rats. Aceves J; Floran B; Martinez-Fong D; Benitez J; Sierra A; Flores G Neurosci Lett; 1992 Sep; 145(1):40-2. PubMed ID: 1461565 [TBL] [Abstract][Full Text] [Related]
14. Adenosine A1 receptors control dopamine D1-dependent [(3)H]GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat. Florán B; Barajas C; Florán L; Erlij D; Aceves J Neuroscience; 2002; 115(3):743-51. PubMed ID: 12435413 [TBL] [Abstract][Full Text] [Related]
15. Dopamine D1 heteroreceptors on striatonigral axons are not stimulated by endogeneous dopamine either tonically or after amphetamine: evidence from terminal excitability. Ryan LJ; Diana M; Young SJ; Groves PM Exp Brain Res; 1989; 77(1):161-5. PubMed ID: 2529134 [TBL] [Abstract][Full Text] [Related]
16. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons. Cole DG; Kobierski LA; Konradi C; Hyman SE Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9631-5. PubMed ID: 7937819 [TBL] [Abstract][Full Text] [Related]
17. Dopamine mediated responses in 6-hydroxydopamine lesioned rats involve changes of the signal transduction. Barone P; Popoli M; Morelli M; Cicarelli G; Campanella G; Di Chiara G J Neural Transm Suppl; 1995; 45():83-90. PubMed ID: 8748613 [TBL] [Abstract][Full Text] [Related]
18. Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms. Lindskog M; Svenningsson P; Fredholm BB; Greengard P; Fisone G Neuroscience; 1999; 88(4):1005-8. PubMed ID: 10336115 [TBL] [Abstract][Full Text] [Related]
19. Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): studies of tremulous jaw movements in rats. Mayorga AJ; Trevitt JT; Conlan A; Gianutsos G; Salamone JD Psychopharmacology (Berl); 1999 Mar; 143(1):72-81. PubMed ID: 10227082 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of (-)-stepholidine on protein phosphorylation of a dopamine- and cAMP-regulated phosphoprotein in denervated striatum of oxidopamine-lesioned rats. Guo X; Liu J; Zou LL; Jin J; Wang BC; Jin GZ Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):100-3. PubMed ID: 10374628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]